References:

1. Abe, K., and H. Kimura, 1996. The possible role of hydrogen sulfide as an endogenous
neuromodulator. Journal of Neuroscience., 16(3):1066-1071.
2. Alshorafa, A. K., Q. Guo, F. Zeng, M. Chen, G. Tan, Z. Tang, and R. Yin, R. 2012. Psoriasis
is associated with low serum levels of hydrogen sulfide, a potential anti-inflammatory
molecule. The Tohoku journal of experimental medicine., 228(4):325-332.
3. Bos, E. M., H. van Goor, J. A. Joles, M. Whiteman, and H. G. Leuvenink, 2015. Hydrogen
sulfide: physiological properties and therapeutic potential in ischaemia. British journal
of pharmacology., 172(6):1479-1493.
4. Fu, M., W. Zhang, L. Wu, G. Yang, H. Li, and R. Wang, 2012. Hydrogen sulfide (H2S)
metabolism in mitochondria and its regulatory role in energy production. Proceedings
of the National Academy of Sciences., 109(8):2943-2948.
5. Hu, L. F., M. Lu, C. X. Tiong, G. S. Dawe, G. Hu, S. J. Bian, 2010. Neuroprotective effects
of hydrogen sulfide on Parkinson’s disease rat models. Aging cell., 9(2):135-146.
6. Jiang, B., G. Tang, K. Cao, L. Wu, L., R. Wang, 2010. Molecular mechanism for H 2S-
induced activation of KATP channels. Antioxidants & redox signaling., 12(10):1167-1178.
7. Kimura, Y., R. Dargusch, D. Schubert, D, and H. Kimura, 2006. Hydrogen sulfide protects
HT22 neuronal cells from oxidative stress. Antioxidants & redox signaling., 8(3-4):661-
670.
8. Kimura, Y., Y. I. Goto, and H. Kimura, H. 2010. Hydrogen sulfide increases glutathione
production and suppresses oxidative stress in mitochondria. Antioxidants & redox
signaling,. 12(1: 1-13.
9. Kimura, H., N. Shibuya, Y. Kimura, 2012. Hydrogen sulfide is a signaling molecule and a
cytoprotectant. Antioxidants & redox signaling., 17(1),:45-57.
10. Li, L., M. Whiteman, Y.Y. Guan, K. L. Neo, Y. Cheng, S. W. Lee, and P. K. Moore, 2008.
Characterization of a novel, water-soluble hydrogen sulfide-releasing molecule
(GYY4137). Circulation., 117(18):2351-2360.
11. Li, L., M. Salto-Tellez, C. H. Tan, M. Whiteman, and P. K. Moore, 2009. GYY4137, a novel
hydrogen sulfide-releasing molecule, protects against endotoxin shock in the rat. Free
Radical Biology and Medicine., 47(1):103-113.
12. Liu, Y. H., M. Lu, and J. S. Bian, 2011. Hydrogen sulfide and renal ischemia. Expert review
of clinical pharmacology., 4(1), 49-61.
13. Liang, G. H., Q. Xi, C. W. Leffler, and J. H. Jaggar, 2012. Hydrogen sulfide activates Ca2+
sparks to induce cerebral arteriole dilatation. The Journal of physiology., 590(11): 2709-
2720.
14. Liu, Y. Y., J. S. Bian, 2012. Hydrogen Sulfide Protects Amyloid-Induced Cell Toxicity in
Microglia. Journal of Alzheimer’s Disease., 31:453.
15. Martelli, A., L. Testai, A. Marino, C. M. Breschi, F. Da Settimo, F, and V. Calderone, 2012.
Hydrogen sulphide: biopharmacological roles in the cardiovascular system and
pharmaceutical perspectives. Current medicinal chemistry., 19(20):3325-3336.
16. Mustafa, A., K., Gadalla, M. M., Sen, N., Kim, S., Mu, W., Gazi, S. K. and Snyder, S. H.
2009. H2S signals through protein S-sulfhydration. Sci. Signal., 2(96):72-72.
17. Olas, B., 2014. Anti-Aggregatory Potential of Selected Vegetables—Promising Dietary
Components for the Prevention and Treatment of Cardiovascular Disease. Advances in
Nutrition., 3(6):2
18. Ping, N. N., S. Li, Y. Mi, N. L. Cao, L., and Y. X. Cao, 2015. Hydrogen sulphide induces
vasoconstriction of rat coronary artery via activation of Ca2+ influx. Acta
Physiologica., 214(1):88-96.
19. Predmore, B. L., Lefer, D. J., & Gojon, G. (2012). Hydrogen sulfide in biochemistry and
medicine. Antioxidants & redox signaling, 17(1), 119-140.
20. Renga, B., 2011. Hydrogen sulfide generation in mammals: the molecular biology of
cystathionine-β-synthase (CBS) and cystathionine-γ-lyase (CSE). Inflammation &
Allergy-Drug Targets (Formerly Current Drug Targets-Inflammation & Allergy., 10(2):
85-91.
21. Reiffenstein, R. J., 1992. Hulbert WC, Roth SH. Toxicology of hydrogen sulfide. Annu Rev
Pharmacol Toxicoi., 32:109-134.
22. Shibuya, N., Y. Mikami, Y. Kimura, N. Nagahara, and H. Kimura, 2009. Vascular
endothelium expresses 3-mercaptopyruvate sulfurtransferase and produces hydrogen
sulfide. The journal of biochemistry., 146(5): 623-626.
23. Szabó, C., 2007. Hydrogen sulphide and its therapeutic potential. Nature reviews Drug
discovery., 6(11): 917.
24. Wallace J. L., R. Wang, 2015. Hydrogen sulfide-based therapeutics: exploiting a unique
but ubiquitous gasotransmitter. Nat Rev Drug Discov., 14:329-45
25. Wallace, J. L., R. W. Blackler, M. V. Chan, G. J. Da Silva, W. Elsheikh, K. L. Flannigan, and
A. G. Buret, 2015. Anti-inflammatory and cytoprotective actions of hydrogen sulfide:
translation to therapeutics. Antioxidants & redox signaling., 22(5):398-410.
26. Wang, Q., X. L. Wang, H. R. Liu, P. Rose, and Y. Z. Zhu, 2010. Protective effects of cysteine
analogues on acute myocardial ischemia: novel modulators of endogenous H2S
production. Antioxidants & redox signaling., 12(10):1155-1165.
27. Wang, R. U. I., 2002. Two’s company, three’sa crowd: can H2S be the third endogenous
gaseous transmitter? The FASEB journal., 16(13):1792-1798.
28. Wang, R., 2012. Physiological implications of hydrogen sulfide: a whiff exploration that
blossomed. Physiological reviews., 92(2):791-896.
29. Wu, D., Q. Q. Hu, Y. Zhu, 2016. Therapeutic application of hydrogen sulfide donors: the
potential and challenges. Frontiers of medicine., 10(1):18-27.
30. Sidhapuriwala, J. N., A. Hegde, A. D. Ang, Y. Z. Zhu, M. Bhatia, 2012. Effects of S-
propargyl-cysteine (SPRC) in caerulein-induced acute pancreatitis in mice. PloS
one., 7(3):32574.
31. Shibuya, N., M. Tanaka, M. Yoshida, Y. Ogasawara, T. Togawa, K. Ishii, and H. Kimura,
H. 2009. 3-Mercaptopyruvate sulfurtransferase produces hydrogen sulfide and bound
sulfane sulfur in the brain. Antioxidants & redox signaling., 11(4):703-714.
32. Shukla, N., G. Rossoni, M. Hotston, A. Sparatore, P. Del Soldato, V. Tazzari, V. and J. Y.
Jeremy, 2009. Effect of hydrogen sulphide‐donating sildenafil (ACS6) on erectile
function and oxidative stress in rabbit isolated corpus cavernosum and in hypertensive
rats. BJU international., 103(11):1522-1529.
33. Suzuki, K., G. Olah, K. Modis, C. Coletta, G. Kulp, D. Gerö, and R. Wang, 2011. Hydrogen
sulfide replacement therapy protects the vascular endothelium in hyperglycemia by
preserving mitochondrial function. Proceedings of the National Academy of Sciences.,
108(33):13829-13834.
34. Tang, G., L. Wu, W. Liang, W., and R. Wang, 2005. Direct stimulation of KATP channels by
exogenous and endogenous hydrogen sulfide in vascular smooth muscle
cells. Molecular pharmacology, 68(6):1757-1764.
35. Xu, Z. S., X.Y. Wang, D. M. Xiao, L. F. Hu, M. Lu, Z. Y. Wu and S. J. Bian, 2011. Hydrogen
sulfide protects MC3T3-E1 osteoblastic cells against H2O2-induced oxidative
damageimplications for the treatment of osteoporosis. Free Radical Biology and
Medicine., 50(10):1314-1323.
36. Zheng, Y., X. Ji, K. Ji, and B. Wang, 2015. Hydrogen sulfide prodrugs a review. Acta
Pharmaceutica Sinica B., 5(5): 367-377.
37. Zhang, H., C. D. Guo, A. Wu, T. Zhang, L. Gu, and C. Wang, 2012. Hydrogen sulfide
inhibits the development of atherosclerosis with suppressing CX3CR1 and CX3CL1
expression. PloS one., 7(7):41147.
38. Zhong, X., L. Wang, Y. Wang, S. Dong, X. Leng, J. Jia, and G. Yang, G. 2012. Exogenous
hydrogen sulfide attenuates diabetic myocardial injury through cardiac mitochondrial
protection. Molecular and cellular biochemistry, 371(1-2):187-198.